Subjects: H.R.5334 — 112th Congress (2011-2012)

  • Administrative law and regulatory procedures
  • Congressional oversight
  • Department of Health and Human Services
  • Drug safety, medical device, and laboratory regulation
  • Food and Drug Administration (FDA)
  • Health